The specificity of GPER antibody (ab39742) has been confirmed from negative control expression studies of a GPER knockdown in two gastric cancer cell lines (Xu et al., 2020) and in striatal tissue (Chen et al., 2019). The gene discussed is GPER1; the disease is gastric cancer.